you are here: HomeNewsBiocon
biocon
Jump to
1508 Results Found
  • Buy Biocon: target of Rs 520: Sharekhan Dec 29, 2020 12:20 PM IST

    Buy Biocon: target of Rs 520: Sharekhan

    Sharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 520 in its research report dated December 28, 2020.

  • Biocon share price rises 2% on launch of Tacrolimus capsules in US Dec 29, 2020 09:47 AM IST

    Biocon share price rises 2% on launch of Tacrolimus capsules in US

    The share touched its 52-week high Rs 487.70 and 52-week low Rs 235.80 on 23 December, 2020 and 19 March, 2020, respectively.

  • Biocon share price slips after CLSA retains 'sell' call, expects stock to dip to Rs 250 Dec 28, 2020 10:19 AM IST

    Biocon share price slips after CLSA retains 'sell' call, expects stock to dip to Rs 250

    Biocon Biologics, and Mylan have been informed by the US health regulator of deferred action on the biologics licence application for a biosimilar to drug Avastin, used to treat various types of cancers, Biocon said.

  • Her father's daughter: Avani Singh focuses on the low-cost model of Ajay Singh's SpiceJet to disrupt COVID-19 testing market Dec 18, 2020 03:24 PM IST

    Her father's daughter: Avani Singh focuses on the low-cost model of Ajay Singh's SpiceJet to disrupt COVID-19 testing market

    Avani, daughter of SpiceJet Chairman & MD Ajay Singh, is the CEO of SpiceHealth

  • Kotak Wealth Hurun - Leading Wealthy Women's 2nd edition | HCL Technologies' Roshni Nadar is the wealthiest Indian woman; here's the full list Dec 03, 2020 05:46 PM IST

    Kotak Wealth Hurun - Leading Wealthy Women's 2nd edition | HCL Technologies' Roshni Nadar is the wealthiest Indian woman; here's the full list

    With a net worth of Rs 54,850 crore, HCL Technologies Chairperson Roshni Nadar Malhotra is India's richest women in 2020, according to a study by Kotak Wealth and Hurun India. Biocon Chairperson Kiran Mazumdar-Shaw is the second-richest woman on the list, with a net worth of 36,600 crore, followed by Leena Gandhi Tewari, Chairperson of USV (Rs 21,340 crore). The cumulative wealth of the 100 women on the list is Rs 2.73 lakh crore, the study said. Here are India's richest women in 2020, as per the Kotak Wealth Hurun list:

  • Roshni Nadar tops Kotak Wealth and Hurun India's list of richest women Dec 03, 2020 03:36 PM IST

    Roshni Nadar tops Kotak Wealth and Hurun India's list of richest women

    Biocon Chairperson Kiran Mazumdar-Shaw is the second-richest woman on the list, with a net worth of 36,600 crore

  • Need global partnerships to become atmanirbhar, says Kiran Mazumdar-Shaw: Report Dec 03, 2020 01:23 PM IST

    Need global partnerships to become atmanirbhar, says Kiran Mazumdar-Shaw: Report

    To attain self-reliance, Indian companies still need to harness innovation through international partnerships and collaborations, Kiran Mazumdar-Shaw has said.

  • Laurus Labs: Foray into biotech adds new lever of growth; accumulate Dec 02, 2020 09:45 AM IST

    Laurus Labs: Foray into biotech adds new lever of growth; accumulate

    Efforts to diversify will open up new opportunities for Laurus Labs and make it move towards a higher-margin trajectory

  • IPO-bound Biocon Biologics in talks with Abu Dhabi fund ADQ to raise fresh capital Nov 24, 2020 12:21 PM IST

    IPO-bound Biocon Biologics in talks with Abu Dhabi fund ADQ to raise fresh capital

    If the negotiations fructify— coming two weeks after the Goldman Sachs deal—it would mark the fourth successive investment in the Kiran Mazumdar Shaw-led Biocon unit in 2020.The last fundraise was struck at a valuation of $3.94 billion.

  • ZS PRIZE: Healthcare innovation challenge seeks ideas for Rs 1 crore prize money Nov 21, 2020 04:06 PM IST

    ZS PRIZE: Healthcare innovation challenge seeks ideas for Rs 1 crore prize money

    ZS PRIZE is open to students and professionals from the start-up, enterprise, and NGO sectors of India. Indian citizens above the age of 18 can submit their ideas or solution prototypes till December 21, 2020

  • Goldman Sachs to invest $150 million in Biocon's IPO-bound subsidiary Biocon Biologics Nov 07, 2020 04:04 PM IST

    Goldman Sachs to invest $150 million in Biocon's IPO-bound subsidiary Biocon Biologics

    As per the terms of the proposed agreement, Goldman Sachs will be issued Optionally Convertible Debentures at a post money equity valuation of $3.94 billion. The transaction is subject to customary approvals and conditions

  • Neutral Biocon; target of Rs 400: Motilal Oswal Oct 27, 2020 06:58 PM IST

    Neutral Biocon; target of Rs 400: Motilal Oswal

    Motilal Oswal recommended Neutral rating on Biocon with a target price of Rs 400 in its research report dated October 23, 2020.

  • Buy Biocon; target of Rs 495: Sharekhan Oct 27, 2020 04:02 PM IST

    Buy Biocon; target of Rs 495: Sharekhan

    Sharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 495 in its research report dated October 23, 2020.

  • Buy Biocon; target of Rs 500: ICICI Direct Oct 27, 2020 02:11 PM IST

    Buy Biocon; target of Rs 500: ICICI Direct

    ICICI Direct is bullish on Biocon recommended buy rating on the stock with a target price of Rs 500 in its research report dated October 23, 2020.

  • Biocon Consolidated September 2020 Net Sales at Rs 1,744.80 crore, up 10.98% Y-o-Y Oct 27, 2020 09:41 AM IST

    Biocon Consolidated September 2020 Net Sales at Rs 1,744.80 crore, up 10.98% Y-o-Y

  • Biocon Standalone September 2020 Net Sales at Rs 560.00 crore, up 6.89% Y-o-Y Oct 27, 2020 09:33 AM IST

    Biocon Standalone September 2020 Net Sales at Rs 560.00 crore, up 6.89% Y-o-Y

  • Biocon Consolidated September 2020 Net Sales at Rs 1,744.80 crore, up 10.98% Y-o-Y Oct 26, 2020 08:25 PM IST

    Biocon Consolidated September 2020 Net Sales at Rs 1,744.80 crore, up 10.98% Y-o-Y

  • Biocon Standalone September 2020 Net Sales at Rs 560.00 crore, up 6.89% Y-o-Y Oct 26, 2020 08:13 PM IST

    Biocon Standalone September 2020 Net Sales at Rs 560.00 crore, up 6.89% Y-o-Y

  • Kiran Mazumdar Shaw says COVID-19 vaccine may be available by June 2021 Oct 24, 2020 01:41 PM IST

    Kiran Mazumdar Shaw says COVID-19 vaccine may be available by June 2021

    Shaw says vaccine candidates will first be approved for emergency use and full approval will come only after evaluating the durability of response.

  • SEBI levies fine on Biocon employee for violating insider trading norms Oct 23, 2020 07:14 PM IST

    SEBI levies fine on Biocon employee for violating insider trading norms

    The employee, Vandana Singh (noticee), general manager regulatory affair of Biocon at the time of investigation and also a designated person, is facing a fine of Rs 3 lakh for violating provisions of Prohibition of Insider Trading (PIT) norms.

  • Biocon Q2 net profit down 23% at Rs 195 crore Oct 23, 2020 01:51 PM IST

    Biocon Q2 net profit down 23% at Rs 195 crore

    It had posted a net profit of Rs 253.8 crore for the July-September quarter previous fiscal, Biocon said in a late-night BSE filing on Thursday.

  • Exclusive | Goldman Sachs Private Equity in talks to buy minority stake in IPO-bound Biocon Biologics Oct 01, 2020 09:29 PM IST

    Exclusive | Goldman Sachs Private Equity in talks to buy minority stake in IPO-bound Biocon Biologics

    If the deal — which may value the firm in excess of $3.5 billion — fructifies, it would mark the third successive investment in 2020 for Kiran Mazumdar Shaw-led Biocon Biologics

  • Cadila: a formidable play in Covid times and beyond Sep 25, 2020 09:39 AM IST

    Cadila: a formidable play in Covid times and beyond

    Cadila is not only a credible Indian pharma striving for a Covid solution, but on a longer time scale is an interesting watch in the large-cap space witnessing a significant transformation in product portfolio.

  • Biocon shares jump 5% on launch of diabetes drug in US Sep 01, 2020 11:13 AM IST

    Biocon shares jump 5% on launch of diabetes drug in US

    As per a regulatory filing on BSE, Biocon Biologics India, a subsidiary of Biocon, and Mylan N.V., announced the US launch of Semglee.

  • Nifty may move towards 11,500; these three bets could give up to 16% returns Aug 19, 2020 08:28 AM IST

    Nifty may move towards 11,500; these three bets could give up to 16% returns

    Technically we believe the index is expected to swing above the upper bound of the 'Broadening formation (11,377)' & move towards 11,500 zone swiftly.

Sections